Trials / Completed
CompletedNCT01781702
Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap. in Rheumatoid Arthritis Patients
A Randomized, Double-blind, Multicenter, Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap. for Comparative Evaluation of Safety & Efficacy in Rheumatoid Arthritis Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Double-blind, Multicenter, Phase 3 Study of Pelubiprofen Tab. \& Celebrex Cap. for Comparative Evaluation of Safety \& Efficacy in Rheumatoid Arthritis Patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pelubiprofen 30 mg | |
| DRUG | Celebrex 200 mg |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2013-02-01
- Last updated
- 2013-08-09
Source: ClinicalTrials.gov record NCT01781702. Inclusion in this directory is not an endorsement.